Biblio Discovery — Demo Discovery Service

6 hasil untuk "Flora Musuamba"

Menampilkan 1–6 · 0,30 detik · RSS

  1. Artikel Jurnal

    From animal testing to model-informed drug development: building on ICH M15 and EMA initiatives to make new approach methodologies (NAMs) deliver

    Jean-Michel Dogné; Médéa Locquet; Flora Musuamba dkk.

    Frontiers in Pharmacology, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    The transition from animal-based experimentation toward New Approach Methodologies (NAMs) requires not only technological innovation but also regulatory frameworks that enable evidence-based decision-making. We discuss how the European Medicines Agency’s evolving strategy for regulatory acceptance…

  2. Artikel Jurnal

    Assessment and Benchmarking of Model Informed Approaches in Drug Development for Hemoglobinopathies: A Review of Scientific Advices From January 2000 to December 2024

    Grace Shalom Govere; Jean‐Michel Dogné; Flora Musuamba

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 15 No. 3 · 2026 · Inggris · DOAJ Scopus

    ABSTRACT Despite the fact that modeling and simulation are now recognized as promising innovative methodologies, their use in the context of development of drugs for sickle cell disease and Thalassemia has not yet been reviewed. Considering the challenges of conducting clinical trials for…

  3. Artikel Jurnal

    Hydroxychloroquine use during the first COVID-19 wave: a case study highlighting the urgent need to enhance research practices within the publication ecosystem

    Charlotte Beaudart; Flora Musuamba; Médéa Locquet dkk.

    Archives of Public Health, Vol. 83 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract The rapid dissemination of scientific findings through media and social networks can profoundly impact public health policies and behaviors. However, the reliability of such data is crucial, as evidenced by significant cases like the retracted study on hydroxychloroquine (HCQ) during the…

  4. Artikel Jurnal Teks lengkap

    In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products

    Marco Viceconti; Francesco Pappalardo; Blanca Rodríguez dkk.

    Methods · 2020 · Inggris · OpenAlex Scopus

    Historically, the evidences of safety and efficacy that companies provide to regulatory agencies as support to the request for marketing authorization of a new medical product have been produced experimentally, either in vitro or in vivo. More recently, regulatory agencies started receiving and…